The rising interest in GLP-1 agonists for diabetes has generated a debate about application forms : patches versus tablets . Traditionally , GLP-1 therapies were exclusively available in oral form, but the https://elodiescrx663193.blogars.com/39489510/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-individuals